In brief
On 27 September 2023, the Italian Medicines Agency (AIFA) published six reports on the monitoring of biosimilar drugs in Italy, regarding the analysis of consumption trends, expenditure trends, regional variability and price trends in the various supply channels, such as territorial distribution, direct distribution and indirect distribution, and consumption trends for intravenous and subcutaneous formulations.
Key takeaways
The reports and in-depth studies are useful support tools for the operators involved in the monitoring and governance of pharmaceutical expenditure to promote the use of expired patent medicines, assess the effectiveness of regional tenders, identify areas for intervention and monitor the effects of the policies introduced. The analyses on regional variability and the savings estimates analysis are particularly relevant.
